Ruiss R, Jochum S, Mocikat R, Hammerschmidt W, Zeidler R (2011)
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.
PloS one, Issue 10, Vol. 6, e25294
DOI: 10.1371/journal.pone.0025294, PubMed: 22022385

Ruiss R, Jochum S, Wanner G, Reisbach G, Hammerschmidt W, Zeidler R (2011)
A virus-like particle-based Epstein-Barr virus vaccine.
Journal of virology, Issue 24, Vol. 85, 13105-13
DOI: 10.1128/JVI.05598-11, PubMed: 21994444

Andratschke M, Luebbers CW, Johannson V, Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B, Gildehaus FJ (2011)
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
Anticancer research, Issue 10, Vol. 31, 3315-21
PubMed: 21965741

Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S, Lang S, Vullo D, Supuran C, Zeidler R (2011)
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.
Cancer immunology, immunotherapy : CII, Issue 5, Vol. 60, 649-58
DOI: 10.1007/s00262-011-0980-z, PubMed: 21298264

Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R (2011)
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.
Cancer immunology, immunotherapy : CII, Issue 5, Vol. 60, 639-48
DOI: 10.1007/s00262-011-0979-5, PubMed: 21293856